NCT03479749View on ClinicalTrials.gov

The Effect of Intra-Articular Injection of RegenoGel-OSP™ (Self-Plasma) and RegenoGel™ on Knee Pain in People Suffering From Osteoarthritis

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 7, 2018

Primary Completion Date

March 4, 2019

Study Completion Date

March 4, 2019

Conditions

Osteoarthritis, Knee

Interventions

DEVICE

RegenoGel-OSP, RegenoGel

RegenoGel-OSP (A) and RegenoGel (B) are visco-supplements intended for the intra-articular treatment of OA.

Trial Locations (5)

Unknown

Hadassah Medical Center, Jerusalem

Shaare Zedek, Jerusalem

Meir Medical Center, Kfar Saba

Tel Aviv Sourasky Medical Center, Tel Aviv

Assaf Harofe Medical Center, Zrifin

All Listed Sponsors

lead

ProCore Ltd.

INDUSTRY

NCT03479749 - The Effect of Intra-Articular Injection of RegenoGel-OSP™ (Self-Plasma) and RegenoGel™ on Knee Pain in People Suffering From Osteoarthritis | Biotech Hunter | Biotech Hunter